ストックスクリーナーアプリを入手
239.53
0.51%
1.21
アフターアワーズ：
239.53
前日終値:
$238.32
開ける：
$240.02
24時間の取引高:
1.44M
Relative Volume:
1.20
時価総額：
$37.82B
収益：
$2.75B
当期純損益:
$714.14M
株価収益率:
55.32
EPS:
4.33
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
+3.21%
1か月 パフォーマンス:
+14.39%
6か月 パフォーマンス:
+1.93%
1年 パフォーマンス:
+18.71%
1日の値動き範囲:
$237.89
$242.00
1週間の範囲:
$231.79
$242.00
52週間の値動き範囲:
$170.25
$258.93
Veeva Systems Inc Stock (VEEV) Company Profile
VEEV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
239.53 | 37.82B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.35 | 10.90B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
65.22 | 8.97B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
91.33 | 7.61B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.49 | 6.83B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-23 | ダウングレード | Goldman | Buy → Sell |
| 2024-12-20 | 開始されました | Stephens | Overweight |
| 2024-12-04 | 開始されました | Mizuho | Outperform |
| 2024-11-19 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-08 | 開始されました | Exane BNP Paribas | Outperform |
| 2024-08-27 | 繰り返されました | Citigroup | Buy |
| 2024-07-09 | 開始されました | BTIG Research | Buy |
| 2023-10-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | 開始されました | Jefferies | Buy |
| 2023-06-28 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-17 | ダウングレード | Truist | Buy → Hold |
| 2023-02-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-01-04 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-12-06 | 開始されました | Cowen | Market Perform |
| 2022-12-02 | 繰り返されました | Needham | Buy |
| 2022-10-31 | 開始されました | Wells Fargo | Equal Weight |
| 2022-10-19 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | Goldman | Buy |
| 2022-06-21 | 再開されました | Guggenheim | Buy |
| 2022-03-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2022-01-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 再開されました | Stifel | Buy |
| 2021-09-02 | 繰り返されました | BofA Securities | Buy |
| 2021-09-02 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2021-09-02 | 繰り返されました | Needham | Buy |
| 2021-09-02 | 繰り返されました | UBS | Neutral |
| 2021-07-21 | 開始されました | Cowen | Outperform |
| 2021-03-31 | アップグレード | UBS | Sell → Neutral |
| 2021-01-07 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-10-14 | 再開されました | UBS | Sell |
| 2020-08-28 | 繰り返されました | Needham | Buy |
| 2020-07-23 | 開始されました | FBN Securities | Outperform |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-06-08 | 開始されました | Citigroup | Buy |
| 2020-05-29 | 繰り返されました | Needham | Buy |
| 2020-04-13 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-02-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-02-14 | 開始されました | Piper Sandler | Overweight |
| 2020-01-13 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | 繰り返されました | Canaccord Genuity | Hold |
| 2019-09-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | 繰り返されました | Needham | Buy |
| 2019-06-07 | 開始されました | Goldman | Neutral |
| 2019-05-30 | 繰り返されました | BofA/Merrill | Buy |
| 2019-05-30 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | 繰り返されました | Needham | Buy |
| 2019-02-27 | 繰り返されました | Needham | Buy |
すべてを表示
Veeva Systems Inc (VEEV) 最新ニュース
Veeva Systems (VEEV) Rises But Trails Market: What Investors Should Know - Yahoo Finance
Veeva to Release Fiscal 2026 First Quarter Results on May 28, 2025 | VEEV Stock News - GuruFocus
Veeva to Release Fiscal 2026 First Quarter Results on May 28, 2025 - Yahoo Finance
eClinical Solutions Market Size to Lead USD 40,500 Million by 2034, Growth in the Biopharmaceutical and Pharmaceutical Industry - GlobeNewswire Inc.
Life Sciences Leaders Advance Unified Engagement at Veeva Commer - GuruFocus
Major Pharma Leaders Join Veeva to Reveal Game-Changing AI Integration for Commercial Operations - Stock Titan
Veeva: Our 2025 Software Pick Just Keeps Winning (NYSE:VEEV) - Seeking Alpha
Connecting Quality and Regulatory for Data-Driven Change Control - Veeva
2024 Veeva Commercial Summit | Veeva - Veeva
June 2026 Options Now Available For Veeva Systems (VEEV) - Nasdaq
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - MSN
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Benzinga
Veeva Systems (NYSE:VEEV) Unveils Veeva AI To Boost Productivity In Life Sciences - Yahoo Finance
Werner Engelbrecht - AI Business
Veeva Systems (VEEV) Introduces Veeva AI to Enhance Life Science - GuruFocus
Veeva Systems Introduces Veeva AI - Contract Pharma
Announcing Veeva AI | VEEV Stock News - GuruFocus
Veeva Systems (VEEV) Introduces Veeva AI to Enhance Life Sciences Automation | VEEV Stock News - GuruFocus
Announcing Veeva AI - marketscreener.com
Here's Why You Should Add Veeva Stock to Your Portfolio Now - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Peering Into Veeva Systems's Recent Short Interest - Benzinga
Veeva (VEEV) Price Target Trimmed by Piper Sandler Amid Industry Challenges | VEEV Stock News - GuruFocus
Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network - Yahoo Finance
Life Science Data Needs an Upgrade: Veeva Has Answers - Fierce Pharma
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock - MSN
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy? - Yahoo Finance
Veeva Systems: Substantially Overvalued As Growth Slows (NYSE:VEEV) - Seeking Alpha
Veeva Systems (NYSE:VEEV) Partners With Flatiron To Enhance Clinical Trial Data Efficiency - Yahoo Finance
Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research - Business Wire
Q4 Earnings Outperformers: Veeva Systems (NYSE:VEEV) And The Rest Of The Vertical Software Stocks - Yahoo Finance
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Veeva Systems’ chief customer officer sells $265,168 in stock By Investing.com - Investing.com India
Veeva Systems’ chief customer officer sells $265,168 in stock - Investing.com
4 Ways Top Sponsors Build Strong and Sustainable Site Relationships - Veeva
Investors Interested In Veeva Systems Inc.'s (NYSE:VEEV) Earnings - simplywall.st
Improve Safety Outputs, Oversight, and Data Quality with In-house Pharmacovigilance Solution - Veeva
B. Braun Transforms Global Clinical Trial Management for Digital Excellence - Veeva
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? - Nasdaq
eClinical Solutions Market Top PlayersMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
ACELYRIN Optimizes the Sponsor-CRO Data Flow with a Centralized Clinical Data Workbench - Veeva
Veeva Systems director Timothy Cabral sells $841,734 in stock By Investing.com - Investing.com Canada
Veeva Systems director Timothy Cabral sells $841,734 in stock - Investing.com
Veeva Systems (VEEV) Gains As Market Dips: What You Should Know - Yahoo Finance
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report? - Yahoo Finance
Veeva Systems (VEEV) Benefited in Q4 From Strong Execution - Insider Monkey
Veeva Systems Inc (VEEV) 財務データ
収益
当期純利益
現金流量
EPS
1.70%
0.43%
大文字化:
|
ボリューム (24 時間):